[시장보고서]세계의 디지털 PCR 및 실시간 PCR 시장 예측(-2029년) : 시장 규모, 점유율, 동향 : 제공별, 용도별

세계의 디지털 PCR 및 실시간 PCR 시장 예측(-2029년) : 시장 규모, 점유율, 동향 : 제공별, 용도별

Digital PCR Market / Digital PCR and Real-time PCR Market Size, Share & Trends by Offering (Product, Software, Services), Application (Clinical, Research, Forensic, Environmental) - Global Forecast to 2029

상품코드 : 1507359 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2024년 07월

페이지 정보 : 영문 599 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,201,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,675,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,857,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,549,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 디지털 PCR(dPCR)·실시간 PCR(qPCR) 시장 규모는 2024년 100억 달러에서 2029년까지 148억 달러에 달할 것으로 예측되며, 2024-2029년의 예측 기간에 CAGR로 8.1%의 성장이 전망됩니다.

시장의 성장은 질병 진단 용도를 향한 병원 및 진단 검사실에서의 채택 증가, 주요 기업에 의한 혁신적인 제품의 개발과 발매를 향한 연구개발 투자의 증가, PCR 기술의 지속적 진보에 의해 크게 촉진되고 있습니다. 그러나 특히 dPCR의 높은 기구 비용과 PCR의 기술적 한계가 시장 성장을 억제하고 있습니다.

조사 범위
조사 대상년	2022-2029년
기준년	2023년
예측 기간	2024-2029년
단위	달러
부문	제공별, 용도별, 최종사용자별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

"용도별로는 2023년 임상용도 부문 중 감염성 질환 검사 부문이 가장 큰 점유율을 차지했습니다."

2023년, 임상 용도 중 감염성 질환 검사 부문이 가장 큰 시장 점유율을 차지했으며, qPCR은 병원균을 신속하고 민감하게 특이적으로 검출할 수 있으며, 감염성 질환 진단에 혁명을 일으켰습니다. 박테리아, 바이러스, 곰팡이, 기생충을 식별하여 조기 진단과 효과적인 치료를 가능하게 합니다. 지난 10년간 전 세계 임상 실험실에서 qPCR을 병원체 검사 및 감염 및 성병 진단에 사용하는 사례가 증가하고 있습니다. 분광법 및 액체 크로마토그래피와 같은 첨단 분자진단 툴이 qPCR 워크플로우와 통합되어 유전체 검사자에게 신속하고 정확한 병원체 검출 능력을 제공합니다.

"미국이 2024-2029년의 예측 기간 중 시장을 계속 지배할 것입니다."

미국은 세계 최대 바이오의약품 시장이자 바이오의약품 연구/투자의 선두주자입니다. 디지털 PCR(dPCR) 및 실시간 PCR(qPCR) 제품에 대한 수요는 감염성 질환 환자 수 증가, 바이오의약품에 대한 관심 증가, 의료 산업에서 안전하고 우수한 품질의 제품에 대한 요구 등으로 인해 향후 수년간 확대될 것으로 예상됩니다. 인도는 우수한 인프라, 정부 지원 및 민간 자금의 존재로 인해 연구개발 측면에서 매우 발전된 시장입니다. 이는 혁신적인 첨단 연구 기술 개발에 도움이 되고 있습니다. 미국 제약사들은 새로운 시약 및 테스트 분석법 개발에 적극적으로 참여하고 있으며, 디지털 PCR(dPCR)과 실시간 PCR(qPCR)을 활용하고 있습니다. 이러한 요인들이 국내 디지털 PCR(dPCR) 및 실시간 PCR(qPCR) 시장의 성장을 지원하고 있습니다.

세계의 디지털 PCR·실시간 PCR 시장에 대해 조사분석했으며, 주요 촉진요인과 억제요인, 경쟁 구도, 향후 동향 등의 정보를 제공하고 있습니다.

서론
시장 역학
- 촉진요인
- 억제요인
- 기회
- 과제
Porter's Five Forces 분석
고객의 비즈니스에 영향을 미치는 동향/혼란
기술 분석
- 주요 기술
- 보완 기술
- 인접 기술
공급망 분석
밸류체인 분석
가격 분석
에코시스템 분석
- dPCR/qPCR 시장 : 원재료 공급업체의 역할
- dPCR/qPCR 시장 : 제조업체의 역할
- dPCR/qPCR 시장 : 최종사용자의 역할
- dPCR/qPCR 시장 : 규제기관의 역할
특허 분석
주요 컨퍼런스와 이벤트(2024-2025년)
규제 상황
- 규제기관, 정부기관, 기타 조직
- 규제 시나리오
주요 이해관계자와 구입 기준
투자와 자금조달 시나리오
무역 분석

제6장 dPCR/qPCR 시장 : 제공별

서론
qPCR 제공
- qPCR 제품
- qPCR 소프트웨어
- qPCR 서비스
dPCR 제공
- dPCR 제품
- dPCR 소프트웨어
- dPCR 서비스

제7장 dPCR/qPCR 시장 : 용도별

서론
qPCR의 용도
- 임상 용도
- 연구 용도
- 법의학 용도
- 환경 용도
- 기타 qPCR의 용도
dPCR의 용도
- 임상 용도
- 연구 용도
- 법의학 용도
- 환경 용도
- 기타 dPCR의 용도

제8장 dPCR/qPCR 시장 : 최종사용자별

서론
qPCR 최종사용자
- 병원, 진단 검사실
- 학술·연구기관
- 제약·바이오테크놀러지 기업
- CROS, CDMOS
- 법의학 연구소
- 기타 최종사용자
dPCR 최종사용자
- 병원, 진단 검사실
- 학술·연구기관
- 제약·바이오테크놀러지 기업
- CROS, CDMOS
- 법의학 연구소
- 기타 최종사용자

제9장 dPCR/qPCR 시장 : 지역별

서론
북미
- 북미에 대한 불황의 영향
- 미국
- 캐나다
유럽
- 유럽에 대한 불황의 영향
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 아시아태평양에 대한 불황의 영향
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
라틴아메리카
- 라틴아메리카에 대한 불황의 영향
- 브라질
- 멕시코
- 기타 라틴아메리카
중동
- 중동에 대한 불황의 영향
- GCC 국가
- 기타 중동
아프리카

제10장 경쟁 구도

서론
주요 기업 전략/유력 기업
매출 분석
시장 점유율 분석
기업의 평가 매트릭스 : 주요 기업(2023년)
기업의 평가 매트릭스 : 스타트업/중소기업(2023년)
기업의 평가와 재무 지표
브랜드/제품의 비교 분석
경쟁 시나리오

제11장 기업 개요

주요 기업
- DANAHER CORPORATION
- F. HOFFMANN-LA ROCHE LTD.
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGAA
- QIAGEN N.V.
- BIO-RAD LABORATORIES, INC.
- AGILENT TECHNOLOGIES, INC.
- TAKARA BIO INC.
- BECTON, DICKINSON, AND COMPANY
- ABBOTT LABORATORIES
- PROMEGA CORPORATION
- MERIDIAN BIOSCIENCE
- ENDRESS+HAUSER GROUP SERVICES AG
- BIOMERIEUX
- EPPENDORF AG
- QUIDELORTHO CORPORATION
- ENZO BIOCHEM INC.
- LEPU MEDICAL TECHNOLOGY CO., LTD.
- SYSMEX CORPORATION
스타트업/중소기업
- BIOCARTIS
- STILLA
- ANTYLIA SCIENTIFIC
- BIONEER CORPORATION
- STANDARD BIOTOOLS
- SEEGENE INC.
- GENSCRIPT
- LGC BIOSEARCH TECHNOLOGIES
- QUANTABIO
- RANDOX LABORATORIES LTD.
- NEW ENGLAND BIOLABS
- PCR BIOSYSTEMS

제12장 부록

KSA

영문 목차

영문목차

The global digital PCR (dPCR) and real-time PCR (qPCR) market is projected to reach USD 14.8 billion by 2029 from USD 10.0 billion in 2024, at a CAGR of 8.1% during the forecast period of 2024 to 2029. The growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market has been significantly driven by its increasing adoption among hospital and diagnostics laboratories for disease diagnosis application, increasing R&D investment by key players for the development and launch of innovative product and continuous advancements in PCR technologies. However, high instrument costs especially that of dPCR and the technical limitations of PCR are restraining market growth.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	By Offering, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The infectious disease testing segment under clinical application segment accounted for the largest share by application in 2023."

In 2023, the infectious disease testing segment under clinical application segment accounted for the largest share by application in the global digital PCR (dPCR) and real-time PCR (qPCR) market. qPCR has revolutionized infectious disease diagnostics by providing rapid, sensitive, and specific detection of pathogens. It is useful in identifying bacteria, viruses, fungi, and parasites, enabling early diagnosis and effective treatment. During the past decade, clinical laboratories worldwide have been increasing using qPCR for pathogen testing and the diagnosis of infectious and sexually transmitted diseases. Advanced molecular diagnosis tools such as spectroscopy and liquid chromatography are being integrated with qPCR workflows to offer genomic lab technicians the capability of rapid and accurate pathogen detection.

"The US has continued to dominate the digital PCR (dPCR) and real-time PCR (qPCR) market during the forecast period of 2024-2029."

The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for digital PCR (dPCR) and real-time PCR (qPCR) products is expected to grow in the coming years, driven by the rising patient population suffering from infectious disease, increasing focus on biopharmaceuticals, and the need for safe & high-quality products in the healthcare industry. The nation has a highly advanced market in terms of R&D due to the presence of better infrastructure, government support, and private funding. This helps develop innovative and advanced technologies for research. Pharmaceutical companies in the US are actively participating in the development of novel reagent and test assays and utilizing it with Digital PCR (dPCR) and real-time PCR (qPCR), which offers less turnaround time, and is energy-efficient also provide accurate results, with in a span of time. These factors are supporting the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market in the country.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Danaher Corporation (US)

F. Hoffmann-La Roche Ltd (Switzerland)

Thermo Fisher Scientific Inc. (US)

Merck KGaA (Germany)

Qiagen N.V. (Germany)

Abbott Laboratories (US)

Biomerieux (France)

Becton, Dickinson and Company (US)

Agilent Technologies, Inc. (US)

Eppendorf AG (Germany)

Bio-Rad Laboratories, Inc. (US)

Takara Bio Inc. (Japan)

Promega Corporation (US)

Meridian Bioscience, Inc. (US)

ENDRESS+HAUSER (Switzerland)

QuidelOrtho Corporation (US)

Lepu Medical Technology Beijing Co Ltd. (China)

Sysmax Corporation (Japan)

Enzo Biochem, Inc. (US)

Biocartis (Belgium)

Stilla Technologies (France)

Antylia Scientific (US)

Bioneer Corporation (South Korea)

Standard BioTools (US)

Seegene Inc. (South Korea)

GenScript (US)

LGC Bioresearch Technologies (England)

Quantabio (US)

Randox Laboratories Ltd. (UK)

New England Biolabs. (US)

PCR Biosystems (UK)

Research Coverage:

This research report categorizes the digital PCR (dPCR) and real-time PCR (qPCR) market by offering ((QPCR product (QPCR Reagents and Consumables, QPCR Instruments), QPCR Software, and QPCR Services) DPCR Product (QPCR Reagents and Consumables, QPCR Instruments (Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR), DPCR Software, and DPCR Services)), by applications ((QPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application), and (DPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application)), by end user ((QPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others), and (DPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others)) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Digital PCR (dPCR) and real-time PCR (qPCR) market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall digital PCR (dPCR) and real-time PCR (qPCR) market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Rising incidence and prevalence of target infectious diseases and genetic disorders, Continuous advancements in PCR technologies, The role of PCR in biomarker discovery, Increased use of dPCR and qPCR technologies for point of care (POC) diagnostics), restraints (High device costs associated with dPCR, Technical limitations of qPCR and dPCR, Unfavorable reimbursement scenario for diagnostic companies), opportunities (Growing market penetration in emerging countries, Integration of qPCR and dPCR with Next-Generation Sequencing (NGS), Growing significance of RT-PCR based companion diagnostics in drug development process), and Challenges (Time Consuming methodology involving in sample handling and post-PCR analysis, Lack of accuracy & standardization in protocol, Availability of alternative technologies for disease diagnosis) influencing the growth of the market).
Product Development/Innovation: Detailed insights on newly launched products of the digital PCR (dPCR) and real-time PCR (qPCR) market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital PCR (dPCR) and real-time PCR (qPCR) market
Competitive Assessment: Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen N.V. (Germany), Abbott Laboratories (US), Biomerieux (France), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Eppendorf AG (Germany), Bio-Rad Laboratories, Inc. (US), Takara Bio Inc. (Japan), among others in the market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKETS COVERED
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 REGIONS COVERED
- FIGURE 1 REGIONAL SEGMENTATION
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
- 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
- FIGURE 2 RESEARCH DESIGN METHODOLOGY
- 2.1.1 SECONDARY RESEARCH
- 2.1.2 PRIMARY RESEARCH
- FIGURE 3 DPCR AND QPCR MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
- FIGURE 4 DIGITAL PCR (DPCR) AND QUANTITATIVE PCR (QPCR) MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
- 2.2.1 GLOBAL MARKET ESTIMATION
- FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
- FIGURE 6 ILLUSTRATIVE EXAMPLE OF QIAGEN N.V.: REVENUE SHARE ANALYSIS (2023)
- 2.2.2 INSIGHTS OF PRIMARY EXPERTS
- FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
- 2.2.3 SEGMENTAL MARKET SIZE ESTIMATION
- FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE PROJECTIONS
- FIGURE 9 DPCR AND QPCR MARKET: CAGR PROJECTIONS, 2024-2029
- TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
- TABLE 2 RISK ASSESSMENT ANALYSIS
2.7 RESEARCH LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

FIGURE 11 QPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 12 DPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 QPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 DPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 QPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 DPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET

4 PREMIUM INSIGHTS

4.1 DIGITAL PCR (DPCR) AND QUANTITATIVE/REAL-TIME PCR (QPCR) MARKET OVERVIEW
- FIGURE 18 RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET DURING FORECAST PERIOD
4.2 ASIA PACIFIC: QPCR MARKET, BY OFFERING AND COUNTRY (2024)
- FIGURE 19 QPCR PRODUCTS SEGMENT IN CHINA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
4.3 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET
- FIGURE 20 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- FIGURE 21 DPCR AND QPCR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- TABLE 3 DPCR AND QPCR MARKET: IMPACT ANALYSIS
- 5.2.1 DRIVERS
  - 5.2.1.1 Rising incidence of infectious diseases and genetic disorders
- TABLE 4 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION (2022)
  - 5.2.1.2 Increasing advancements in PCR technologies
- TABLE 5 CONVENTIONAL PCR VS. QPCR & DPCR
  - 5.2.1.3 Increasing applications of PCR in biomarker discovery
  - 5.2.1.4 Growing focus on dPCR and qPCR technologies for POC diagnostics
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of dPCR instruments
  - 5.2.2.2 Technical limitations associated with qPCR and dPCR
  - 5.2.2.3 Unfavorable reimbursements for diagnostic companies
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 High growth potential of emerging markets
  - 5.2.3.2 Integration of qPCR and dPCR with NGS
  - 5.2.3.3 Growing significance of RT-PCR-based companion diagnostics in drug development
- 5.2.4 CHALLENGES
  - 5.2.4.1 Time constraints associated with sample handling
  - 5.2.4.2 Inadequate protocols for accuracy & standardization
  - 5.2.4.3 Availability of alternative technologies
5.3 PORTER'S FIVE FORCES ANALYSIS
- FIGURE 22 DPCR AND QPCR MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 6 DPCR AND QPCR MARKET: PORTER'S FIVE FORCES ANALYSIS
- 5.3.1 DEGREE OF COMPETITION
- 5.3.2 BARGAINING POWER OF SUPPLIERS
- 5.3.3 BARGAINING POWER OF BUYERS
- 5.3.4 THREAT OF SUBSTITUTES
- 5.3.5 THREAT OF NEW ENTRANTS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 23 DPCR AND QPCR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.5 TECHNOLOGY ANALYSIS
- 5.5.1 KEY TECHNOLOGIES
- TABLE 7 KEY TECHNOLOGIES
- 5.5.2 COMPLEMENTARY TECHNOLOGIES
- TABLE 8 COMPLEMENTARY TECHNOLOGIES
- 5.5.3 ADJACENT TECHNOLOGIES
- TABLE 9 ADJACENT TECHNOLOGIES
5.6 SUPPLY CHAIN ANALYSIS
- FIGURE 24 SUPPLY CHAIN ANALYSIS
5.7 VALUE CHAIN ANALYSIS
- FIGURE 25 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING RAW MATERIAL PROCUREMENT AND MANUFACTURING STAGES
5.8 PRICING ANALYSIS
- TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT (2023)
- FIGURE 26 AVERAGE SELLING PRICE TREND FOR QPCR INSTRUMENTS (2021-2023)
- TABLE 11 AVERAGE SELLING PRICE, BY PRODUCT, BY REGION (2023)
5.9 ECOSYSTEM ANALYSIS
- FIGURE 27 DPCR AND QPCR MARKET: ECOSYSTEM ANALYSIS
- 5.9.1 DPCR AND QPCR MARKET: ROLE OF RAW MATERIAL SUPPLIERS
- TABLE 12 DPCR AND QPCR MARKET: RAW MATERIAL SUPPLIERS
- 5.9.2 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
- TABLE 13 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
- 5.9.3 DPCR AND QPCR MARKET: ROLE OF END USERS
- TABLE 14 DPCR AND QPCR MARKET: ROLE OF END USERS
- 5.9.4 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
- TABLE 15 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
5.10 PATENT ANALYSIS
- 5.10.1 PATENT METHODOLOGY
- 5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
- TABLE 16 PATENTS FILED, 2014-2024
- 5.10.3 INNOVATION & PATENT APPLICATIONS
- FIGURE 28 NUMBER OF PATENTS GRANTED, 2014-2024
- 5.10.4 TOP APPLICANTS
- FIGURE 29 TOP TEN PATENT APPLICANTS, 2014-2024
- TABLE 17 TOP 20 PATENT OWNERS IN QPCR AND DPCR MARKET, 2014-2024
5.11 KEY CONFERENCES AND EVENTS (2024-2025)
- TABLE 18 DPCR AND QPCR MARKET: LIST OF CONFERENCES AND EVENTS (2024-2025)
5.12 REGULATORY LANDSCAPE
- 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 19 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.12.2 REGULATORY SCENARIO
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DPCR & QPCR PRODUCTS
- 5.13.2 KEY BUYING CRITERIA AMONG END USERS
- FIGURE 31 KEY BUYING CRITERIA FOR END USERS
- TABLE 20 BUYING CRITERIA FOR DPCR AND QPCR PRODUCTS, BY END USER
5.14 INVESTMENT & FUNDING SCENARIO
5.15 TRADE ANALYSIS
- TABLE 21 IMPORT VALUE, BY COUNTRY, 2019-2023 (USD THOUSANDS)
- TABLE 22 EXPORT VALUE, BY COUNTRY, 2019-2023 (USD THOUSAND)
- TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019-2023 (TONS)
- TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019-2023 (TONS)

6 DPCR AND QPCR MARKET, BY OFFERING

6.1 INTRODUCTION
- TABLE 25 DPCR AND QPCR MARKET, BY OFFERING, 2022-2029 (USD MILLION)
6.2 QPCR OFFERINGS
- TABLE 26 QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 27 QPCR OFFERING MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 28 NORTH AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 29 EUROPE: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 30 ASIA PACIFIC: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 31 LATIN AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 32 MIDDLE EAST: QPCR OFFERINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 33 GCC COUNTRIES: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- 6.2.1 QPCR PRODUCTS
- TABLE 34 QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  - 6.2.1.1 qPCR reagents & consumables
    - 6.2.1.1.1 Recurring consumption of detection agents to drive market
- TABLE 35 QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 36 NORTH AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 37 EUROPE: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 38 ASIA PACIFIC: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 39 LATIN AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 40 MIDDLE EAST: QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 41 GCC COUNTRIES: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 42 QPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 43 QPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022-2029 (USD MILLION)
  - 6.2.1.2 qPCR instruments
    - 6.2.1.2.1 Advancements in instrument design to drive market
- TABLE 44 INSTALLED BASE FOR QPCR INSTRUMENTS, BY PRODUCT, 2019-2023
- TABLE 45 QPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 46 NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 47 EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 48 ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 49 LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 50 MIDDLE EAST: QPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 51 GCC COUNTRIES: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 52 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 53 QPCR INSTRUMENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- 6.2.2 QPCR SOFTWARE
  - 6.2.2.1 Rising demand for specialized analysis software to support market growth
- TABLE 54 QPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 55 NORTH AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 56 EUROPE: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 57 ASIA PACIFIC: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 58 LATIN AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 59 MIDDLE EAST: QPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 60 GCC COUNTRIES: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 61 QPCR SOFTWARE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 62 QPCR SOFTWARE MARKET, BY END USER, 2022-2029 (USD MILLION)
- 6.2.3 QPCR SERVICES
  - 6.2.3.1 Growing requirement for maintenance and calibration of PCR instruments to fuel market
- TABLE 63 QPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 64 NORTH AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 65 EUROPE: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 66 ASIA PACIFIC: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 67 LATIN AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 68 MIDDLE EAST: QPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 69 GCC COUNTRIES: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 70 QPCR SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 71 QPCR SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
6.3 DPCR OFFERINGS
- TABLE 72 DPCR OFFERINGS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 73 DPCR OFFERINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 74 NORTH AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 75 EUROPE: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 76 ASIA PACIFIC: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 77 LATIN AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 78 MIDDLE EAST: DPCR OFFERINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 79 GCC COUNTRIES: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- 6.3.1 DPCR PRODUCTS
- TABLE 80 DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  - 6.3.1.1 DPCR reagents & consumables
    - 6.3.1.1.1 Availability of novel dPCR reagents to propel market
- TABLE 81 DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 82 NORTH AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 83 EUROPE: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 84 ASIA PACIFIC: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 85 LATIN AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 86 MIDDLE EAST: DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 87 GCC COUNTRIES: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 88 DPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 89 DPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022-2029 (USD MILLION)
  - 6.3.1.2 DPCR instruments
- TABLE 90 DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 91 DPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 92 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 93 EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 94 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 95 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 96 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 97 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 98 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 99 DPCR INSTRUMENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 100 DROPLET DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 101 NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 102 EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 103 ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 104 LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 105 MIDDLE EAST: DROPLET DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 106 GCC COUNTRIES: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 107 CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 108 NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 109 EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 110 ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 111 LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 112 MIDDLE EAST: CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 113 GCC COUNTRIES: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 114 BEAMING DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 115 NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 116 EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 117 ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 118 LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 119 MIDDLE EAST: BEAMING DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 120 GCC COUNTRIES: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- 6.3.2 DPCR SOFTWARE
  - 6.3.2.1 Ability to enhance workflow efficiency to drive market
- TABLE 121 DPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 122 NORTH AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 123 EUROPE: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 124 ASIA PACIFIC: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 125 LATIN AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 126 MIDDLE EAST: DPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 127 GCC COUNTRIES: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 128 DPCR SOFTWARE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 129 DPCR SOFTWARE MARKET, BY END USER, 2022-2029 (USD MILLION)
- 6.3.3 DPCR SERVICES
  - 6.3.3.1 Rising need for application-specific guidance to support market growth
- TABLE 130 DPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 131 NORTH AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 132 EUROPE: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 133 ASIA PACIFIC: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 134 LATIN AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 135 MIDDLE EAST: DPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 136 GCC COUNTRIES: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 137 DPCR SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 138 DPCR SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)

7 DPCR AND QPCR MARKET, BY APPLICATION

7.1 INTRODUCTION
- TABLE 139 QPCR AND DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
7.2 QPCR APPLICATIONS
- TABLE 140 APPLICATION EXAMPLES OF QPCR
- TABLE 141 QPCR APPLICATIONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- 7.2.1 CLINICAL APPLICATIONS
- TABLE 142 QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 143 QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 144 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 145 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 146 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 147 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 148 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 149 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.1.1 Infectious disease testing
    - 7.2.1.1.1 Wide utilization in pathogen testing to fuel market
- TABLE 150 QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 151 NORTH AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 152 EUROPE: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 153 ASIA PACIFIC: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 154 LATIN AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 155 MIDDLE EAST: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 156 GCC COUNTRIES: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.1.2 Oncology testing
    - 7.2.1.2.1 High uptake in tumor screening & classification to boost demand
- TABLE 157 QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 158 NORTH AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 159 EUROPE: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 160 ASIA PACIFIC: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 161 LATIN AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 162 MIDDLE EAST: QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 163 GCC COUNTRIES: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.1.3 Blood screening
    - 7.2.1.3.1 Elimination of post-amplification processing to drive market
- TABLE 164 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 165 NORTH AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 166 EUROPE: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 167 ASIA PACIFIC: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 168 LATIN AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 169 MIDDLE EAST: QPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 170 GCC COUNTRIES: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.1.4 Transplant diagnostics
    - 7.2.1.4.1 Growing preference for genome-based products to fuel market
- TABLE 171 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 172 NORTH AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 173 EUROPE: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 174 ASIA PACIFIC: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 175 LATIN AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 176 MIDDLE EAST: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 177 GCC COUNTRIES: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.1.5 Other clinical applications
- TABLE 178 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 179 NORTH AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 180 EUROPE: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 181 ASIA PACIFIC: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 182 LATIN AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 183 MIDDLE EAST: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 184 GCC COUNTRIES: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.2.2 RESEARCH APPLICATIONS
- TABLE 185 QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 186 QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 187 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 188 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 189 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 190 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 191 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 192 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.2.1 Single-cell analysis
    - 7.2.2.1.1 Growing need for high-resolution molecular data to drive market
- TABLE 193 QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 194 NORTH AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 195 EUROPE: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022-2029 (USD MILLION)
- TABLE 196 ASIA PACIFIC: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022-2029 (USD MILLION)
- TABLE 197 LATIN AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 198 MIDDLE EAST: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 199 GCC COUNTRIES: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.2.2 Stem cell research
    - 7.2.2.2.1 Growing focus on regenerative medicine to boost demand
- TABLE 200 QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 201 NORTH AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 202 EUROPE: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 203 ASIA PACIFIC: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 204 LATIN AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 205 MIDDLE EAST: QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 206 GCC COUNTRIES: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.2.3 Gene expression
    - 7.2.2.3.1 Precise quantification requirements to support market growth
- TABLE 207 QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 208 NORTH AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 209 EUROPE: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 210 ASIA PACIFIC: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 211 LATIN AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 212 MIDDLE EAST: QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 213 GCC COUNTRIES: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.2.2.4 Other research applications
- TABLE 214 QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 215 NORTH AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 216 EUROPE: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 217 ASIA PACIFIC: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 218 LATIN AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 219 MIDDLE EAST: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 220 GCC COUNTRIES: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.2.3 FORENSIC APPLICATIONS
  - 7.2.3.1 Ability to analyze genetic fingerprinting and biological samples to propel market
- TABLE 221 QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 222 NORTH AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 223 EUROPE: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 224 ASIA PACIFIC: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 225 LATIN AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 226 MIDDLE EAST: QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 227 GCC COUNTRIES: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.2.4 ENVIRONMENTAL APPLICATIONS
  - 7.2.4.1 Development of specialized assays for environmental monitoring to drive market
- TABLE 228 QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 229 NORTH AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 230 EUROPE: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 231 ASIA PACIFIC: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 232 LATIN AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 233 MIDDLE EAST: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 234 GCC COUNTRIES: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.2.5 OTHER QPCR APPLICATIONS
- TABLE 235 OTHER QPCR APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 236 NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 237 EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 238 ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 239 LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 240 MIDDLE EAST: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 241 GCC COUNTRIES: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
7.3 DPCR APPLICATIONS
- TABLE 242 DPCR APPLICATIONS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- 7.3.1 CLINICAL APPLICATIONS
- TABLE 243 DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 244 DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 245 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 246 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 247 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 248 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 249 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 250 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.3.1.1 Infectious disease testing
    - 7.3.1.1.1 Accuracy and precision capabilities to boost demand
- TABLE 251 DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 252 NORTH AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 253 EUROPE: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 254 ASIA PACIFIC: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 255 LATIN AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 256 MIDDLE EAST: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 257 GCC COUNTRIES: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.3.1.2 Oncology testing
    - 7.3.1.2.1 Detection and monitoring of cancer-related genetic alterations to drive market
- TABLE 258 DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 259 NORTH AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 260 EUROPE: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 261 ASIA PACIFIC: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 262 LATIN AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 263 MIDDLE EAST: DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 264 GCC COUNTRIES: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION)
  - 7.3.1.3 Blood screening
    - 7.3.1.3.1 Highly sensitive detection of infectious agents to support market growth
- TABLE 265 DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 266 NORTH AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 267 EUROPE: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 268 ASIA PACIFIC: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 269 LATIN AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 270 MIDDLE EAST: DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 271 GCC COUNTRIES: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)

7.3.1.4 Transplant diagnostics
- 7.3.1.4.1 Low market availability to restrain market

TABLE 272 DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 273 NORTH AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 274 EUROPE: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 276 LATIN AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 277 MIDDLE EAST: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 278 GCC COUNTRIES: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.3.1.5 Other clinical applications
TABLE 279 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 280 NORTH AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 281 EUROPE: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 282 ASIA PACIFIC: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 283 LATIN AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 284 MIDDLE EAST: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 285 GCC COUNTRIES: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
7.3.2 RESEARCH APPLICATIONS
- 7.3.2.1 High uptake by pharma & biotech companies for drug screening to drive market
TABLE 286 DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- 7.3.2.2 Single-cell analysis
  - 7.3.2.2.1 dDPCR compatibility with one-step RT-PCR to boost demand
TABLE 287 DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
TABLE 288 NORTH AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 289 EUROPE: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 290 ASIA PACIFIC: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 291 LATIN AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 292 MIDDLE EAST: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
TABLE 293 GCC COUNTRIES: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.3.2.3 Stem cell research
  - 7.3.2.3.1 Growing need for reliable tools to assess stem cell quality & potency to boost demand
TABLE 294 DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 295 NORTH AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 296 EUROPE: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 297 ASIA PACIFIC: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 298 LATIN AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 299 MIDDLE EAST: DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 300 GCC COUNTRIES: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.3.2.4 Gene expression
  - 7.3.2.4.1 Increasing demand for accurate quantification methods in personalized medicine to drive market
TABLE 301 DPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION)
TABLE 302 NORTH AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 303 EUROPE: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 304 ASIA PACIFIC: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 305 LATIN AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 306 MIDDLE EAST: DPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION)
TABLE 307 GCC COUNTRIES: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
- 7.3.2.5 Other research applications
TABLE 308 DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 309 NORTH AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 310 EUROPE: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 311 ASIA PACIFIC: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 312 LATIN AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 313 MIDDLE EAST: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 314 GCC COUNTRIES: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
7.3.3 FORENSIC APPLICATIONS
- 7.3.3.1 DNA profiling benefits to support market growth
TABLE 315 DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 316 NORTH AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 317 EUROPE: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 318 ASIA PACIFIC: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 319 LATIN AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 320 MIDDLE EAST: DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 321 GCC COUNTRIES: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
7.3.4 ENVIRONMENTAL APPLICATIONS
- 7.3.4.1 Increasing demand for wastewater surveillance to drive market
TABLE 322 DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 323 NORTH AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 324 EUROPE: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 325 ASIA PACIFIC: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 326 LATIN AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 327 MIDDLE EAST: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 328 GCC COUNTRIES: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
7.3.5 OTHER DPCR APPLICATIONS
TABLE 329 OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 330 NORTH AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 331 EUROPE: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 332 ASIA PACIFIC: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 333 LATIN AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 334 MIDDLE EAST: OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 335 GCC COUNTRIES: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

8 DPCR AND QPCR MARKET, BY END USER

8.1 INTRODUCTION
- TABLE 336 DPCR AND QPCR MARKET FOR END USERS, BY TECHNOLOGY, 2022-2029 (USD MILLION)
8.2 QPCR END USERS
- TABLE 337 QPCR MARKET FOR END USERS, BY TYPE, 2022-2029 (USD MILLION)
- 8.2.1 HOSPITALS AND DIAGNOSTIC LABORATORIES
  - 8.2.1.1 Growing uptake in disease diagnostics to drive market
- TABLE 338 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 339 NORTH AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 340 EUROPE: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 341 ASIA PACIFIC: QPCR FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 342 LATIN AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 343 MIDDLE EAST: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 344 GCC COUNTRIES: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.2.2 ACADEMIC & RESEARCH INSTITUTES
  - 8.2.2.1 Growing focus on genetic & molecular studies to boost demand
- TABLE 345 QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 346 NORTH AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 347 EUROPE: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 348 ASIA PACIFIC: QPCR FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 349 LATIN AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 350 MIDDLE EAST: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 351 GCC COUNTRIES: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.2.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  - 8.2.3.1 Rising focus on drug discovery & development to propel market
- TABLE 352 QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 353 NORTH AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 354 EUROPE: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 355 ASIA PACIFIC: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 356 LATIN AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 357 MIDDLE EAST: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 358 GCC COUNTRIES: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.2.4 CROS AND CDMOS
  - 8.2.4.1 Increasing outsourcing of drug development activities by pharma companies to boost demand
- TABLE 359 QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 360 NORTH AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 361 EUROPE: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 362 ASIA PACIFIC: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 363 LATIN AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 364 MIDDLE EAST: QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 365 GCC COUNTRIES: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.2.5 FORENSIC LABORATORIES
  - 8.2.5.1 Growing trend of laboratory automation to drive market
- TABLE 366 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 367 NORTH AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 368 EUROPE: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 369 ASIA PACIFIC: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 370 LATIN AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 371 MIDDLE EAST: QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 372 GCC COUNTRIES: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.2.6 OTHER END USERS
- TABLE 373 QPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 374 NORTH AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 375 EUROPE: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 376 ASIA PACIFIC: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 377 LATIN AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 378 MIDDLE EAST: QPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 379 GCC COUNTRIES: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
8.3 DPCR END USERS
- TABLE 380 DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 8.3.1 HOSPITALS AND DIAGNOSTIC LABORATORIES
  - 8.3.1.1 High uptake in genetic testing and embryo DNA profiling to drive market
- TABLE 381 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 382 NORTH AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 383 EUROPE: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, 2022-2029 (USD MILLION)
- TABLE 384 ASIA PACIFIC: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 385 LATIN AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 386 MIDDLE EAST: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 387 GCC COUNTRIES: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.3.2 ACADEMIC & RESEARCH INSTITUTES
  - 8.3.2.1 Rising R&D funding investments to support market growth
- TABLE 388 DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 389 NORTH AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 390 EUROPE: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, 2022-2029 (USD MILLION)
- TABLE 391 ASIA PACIFIC: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 392 LATIN AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 393 MIDDLE EAST: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 394 GCC COUNTRIES: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.3.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  - 8.3.3.1 High uptake in toxicity & clinical studies to drive market
- TABLE 395 DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 396 NORTH AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 397 EUROPE: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 398 ASIA PACIFIC: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 399 LATIN AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 400 MIDDLE EAST: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 401 GCC COUNTRIES: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.3.4 CROS AND CDMOS
  - 8.3.4.1 Rising number of clinical trials to support market growth
- TABLE 402 DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 403 NORTH AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 404 EUROPE: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 405 ASIA PACIFIC: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 406 LATIN AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 407 MIDDLE EAST: DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 408 GCC COUNTRIES: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.3.5 FORENSIC LABORATORIES
  - 8.3.5.1 Development of advanced dPCR assays to support market growth
- TABLE 409 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 410 NORTH AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 411 EUROPE: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 412 ASIA PACIFIC: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 413 LATIN AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 414 MIDDLE EAST: DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 415 GCC COUNTRIES: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- 8.3.6 OTHER END USERS
- TABLE 416 DPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 417 NORTH AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 418 EUROPE: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 419 ASIA PACIFIC: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 420 LATIN AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 421 MIDDLE EAST: DPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 422 GCC COUNTRIES: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)

9 DPCR AND QPCR MARKET, BY REGION

9.1 INTRODUCTION
- TABLE 423 DPCR AND QPCR MARKET, BY REGION, 2022-2029 (USD MILLION)
9.2 NORTH AMERICA
- 9.2.1 NORTH AMERICA: RECESSION IMPACT
- FIGURE 32 NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT
- TABLE 424 NORTH AMERICA: DPCR AND QPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 425 NORTH AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 426 NORTH AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 427 NORTH AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 428 NORTH AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 429 NORTH AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 430 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 431 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 432 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 433 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 434 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 435 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 436 NORTH AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 437 NORTH AMERICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 438 NORTH AMERICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.2.2 US
  - 9.2.2.1 Rising adoption of advanced technologies to drive market
- TABLE 439 US: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 440 US: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 441 US: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 442 US: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 443 US: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 444 US: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 445 US: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 446 US: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 447 US: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 448 US: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 449 US: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 450 US: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 451 US: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 452 US: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.2.3 CANADA
  - 9.2.3.1 Supportive government initiatives for genomics research to drive market
- TABLE 453 CANADA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 454 CANADA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 455 CANADA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 456 CANADA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 457 CANADA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 458 CANADA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 459 CANADA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 460 CANADA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 461 CANADA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 462 CANADA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 463 CANADA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 464 CANADA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 465 CANADA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 466 CANADA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.3 EUROPE
- 9.3.1 EUROPE: RECESSION IMPACT
- TABLE 467 EUROPE: QPCR AND DPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 468 EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 469 EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 470 EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 471 EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 472 EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 473 EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 474 EUROPE: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 475 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 476 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 477 EUROPE: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 478 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 479 EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 480 EUROPE: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 481 EUROPE: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.3.2 GERMANY
  - 9.3.2.1 Rising healthcare expenditure and favorable reimbursements for diagnostic procedures to boost demand
- TABLE 482 GERMANY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 483 GERMANY: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 484 GERMANY: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 485 GERMANY: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 486 GERMANY: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 487 GERMANY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 488 GERMANY: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 489 GERMANY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 490 GERMANY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 491 GERMANY: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 492 GERMANY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 493 GERMANY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 494 GERMANY: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 495 GERMANY: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.3.3 UK
  - 9.3.3.1 Growing focus on genomics research to drive market
- TABLE 496 UK: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 497 UK: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 498 UK: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 499 UK: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 500 UK: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 501 UK: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 502 UK: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 503 UK: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 504 UK: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 505 UK: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 506 UK: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 507 UK: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 508 UK: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 509 UK: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.3.4 FRANCE
  - 9.3.4.1 Supportive government regulations for diagnostic assay procedures to drive market
- TABLE 510 FRANCE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 511 FRANCE: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 512 FRANCE: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 513 FRANCE: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 514 FRANCE: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 515 FRANCE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 516 FRANCE: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 517 FRANCE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 518 FRANCE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 519 FRANCE: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 520 FRANCE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 521 FRANCE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 522 FRANCE: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 523 FRANCE: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.3.5 ITALY
  - 9.3.5.1 Increasing funding investments for development of innovative therapies to fuel market
- TABLE 524 ITALY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 525 ITALY: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 526 ITALY: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 527 ITALY: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 528 ITALY: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 529 ITALY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 530 ITALY: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 531 ITALY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 532 ITALY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 533 ITALY: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 534 ITALY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 535 ITALY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 536 ITALY: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 537 ITALY: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.3.6 SPAIN
  - 9.3.6.1 Rising funding investments for R&D to support market growth
- TABLE 538 SPAIN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 539 SPAIN: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 540 SPAIN: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 541 SPAIN: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 542 SPAIN: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 543 SPAIN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 544 SPAIN: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 545 SPAIN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 546 SPAIN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 547 SPAIN: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 548 SPAIN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 549 SPAIN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 550 SPAIN: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 551 SPAIN: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.3.7 REST OF EUROPE
- TABLE 552 REST OF EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 553 REST OF EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 554 REST OF EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 555 REST OF EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 556 REST OF EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 557 REST OF EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 558 REST OF EUROPE: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 559 REST OF EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 560 REST OF EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 561 REST OF EUROPE: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 562 REST OF EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 563 REST OF EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 564 REST OF EUROPE: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 565 REST OF EUROPE: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.4 ASIA PACIFIC
- 9.4.1 ASIA PACIFIC: RECESSION IMPACT
- FIGURE 33 ASIA PACIFIC: DPCR & QPCR MARKET SNAPSHOT
- TABLE 566 ASIA PACIFIC: QPCR AND DPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 567 ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 568 ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 569 ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 570 ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 571 ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 572 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 573 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 574 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 575 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 576 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 577 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 578 ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 579 ASIA PACIFIC: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 580 ASIA PACIFIC: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)

9.4.2 CHINA
- 9.4.2.1 Modernization of healthcare infrastructure to propel market
TABLE 581 CHINA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 582 CHINA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 583 CHINA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 584 CHINA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 585 CHINA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 586 CHINA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 587 CHINA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 588 CHINA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 589 CHINA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 590 CHINA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 591 CHINA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 592 CHINA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 593 CHINA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 594 CHINA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.4.3 JAPAN
- 9.4.3.1 Rising number of oncology research activities to drive market
TABLE 595 JAPAN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 596 JAPAN: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 597 JAPAN: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 598 JAPAN: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 599 JAPAN: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 600 JAPAN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 601 JAPAN: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 602 JAPAN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 603 JAPAN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 604 JAPAN: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 605 JAPAN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 606 JAPAN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 607 JAPAN: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 608 JAPAN: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.4.4 INDIA
- 9.4.4.1 Growth in pharmaceutical industry to drive market
TABLE 609 INDIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 610 INDIA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 611 INDIA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 612 INDIA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 613 INDIA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 614 INDIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 615 INDIA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 616 INDIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 617 INDIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 618 INDIA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 619 INDIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 620 INDIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 621 INDIA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 622 INDIA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.4.5 AUSTRALIA
- 9.4.5.1 Growth in biopharmaceuticals market sector to fuel market
TABLE 623 AUSTRALIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 624 AUSTRALIA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 625 AUSTRALIA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 626 AUSTRALIA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 627 AUSTRALIA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 628 AUSTRALIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 629 AUSTRALIA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 630 AUSTRALIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 631 AUSTRALIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 632 AUSTRALIA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 633 AUSTRALIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 634 AUSTRALIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 635 AUSTRALIA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 636 AUSTRALIA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.4.6 SOUTH KOREA
- 9.4.6.1 Development of advanced PCR-based diagnostic instruments to support market growth
TABLE 637 SOUTH KOREA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 638 SOUTH KOREA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 639 SOUTH KOREA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 640 SOUTH KOREA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 641 SOUTH KOREA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 642 SOUTH KOREA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 643 SOUTH KOREA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 644 SOUTH KOREA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 645 SOUTH KOREA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 646 SOUTH KOREA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 647 SOUTH KOREA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 648 SOUTH KOREA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 649 SOUTH KOREA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 650 SOUTH KOREA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 651 REST OF ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 652 REST OF ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 653 REST OF ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 654 REST OF ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 655 REST OF ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 656 REST OF ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 657 REST OF ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 658 REST OF ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 659 REST OF ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 660 REST OF ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 661 REST OF ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 662 REST OF ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 663 REST OF ASIA PACIFIC: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 664 REST OF ASIA PACIFIC: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)

9.5 LATIN AMERICA
- 9.5.1 LATIN AMERICA: RECESSION IMPACT
- TABLE 665 LATIN AMERICA: QPCR AND DPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 666 LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 667 LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 668 LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 669 LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 670 LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 671 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 672 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 673 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 674 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 675 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 676 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 677 LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 678 LATIN AMERICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 679 LATIN AMERICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.5.2 BRAZIL
  - 9.5.2.1 High burden of chronic and infectious diseases to propel market
- TABLE 680 BRAZIL: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 681 BRAZIL: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 682 BRAZIL: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 683 BRAZIL: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 684 BRAZIL: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 685 BRAZIL: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 686 BRAZIL: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 687 BRAZIL: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 688 BRAZIL: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 689 BRAZIL: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 690 BRAZIL: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 691 BRAZIL: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 692 BRAZIL: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 693 BRAZIL: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.5.3 MEXICO
  - 9.5.3.1 Growing availability of advanced diagnostic instruments to boost demand
- TABLE 694 MEXICO: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 695 MEXICO: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 696 MEXICO: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 697 MEXICO: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 698 MEXICO: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 699 MEXICO: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 700 MEXICO: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 701 MEXICO: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 702 MEXICO: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 703 MEXICO: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 704 MEXICO: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 705 MEXICO: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 706 MEXICO: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 707 MEXICO: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.5.4 REST OF LATIN AMERICA
- TABLE 708 REST OF LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 709 REST OF LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 710 REST OF LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 711 REST OF LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 712 REST OF LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 713 REST OF LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 714 REST OF LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 715 REST OF LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 716 REST OF LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 717 REST OF LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 718 REST OF LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 719 REST OF LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 720 REST OF LATIN AMERICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 721 REST OF LATIN AMERICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.6 MIDDLE EAST
- 9.6.1 MIDDLE EAST: RECESSION IMPACT
- TABLE 722 MIDDLE EAST: DPCR AND QPCR MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 723 MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 724 MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 725 MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 726 MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 727 MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 728 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 729 MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 730 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 731 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 732 MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 733 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 734 MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 735 MIDDLE EAST: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 736 MIDDLE EAST: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.6.2 GCC COUNTRIES
- TABLE 737 GCC COUNTRIES: DPCR AND QPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 738 GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 739 GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 740 GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 741 GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 742 GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 743 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 744 GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 745 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 746 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 747 GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 748 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 749 GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 750 GCC COUNTRIES: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 751 GCC COUNTRIES: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
  - 9.6.2.1 Kingdom of Saudi Arabia
    - 9.6.2.1.1 Growing healthcare expenditure to boost market
- TABLE 752 KINGDOM OF SAUDI ARABIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 753 KINGDOM OF SAUDI ARABIA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 754 KINGDOM OF SAUDI ARABIA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 755 KINGDOM OF SAUDI ARABIA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 756 KINGDOM OF SAUDI ARABIA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 757 KINGDOM OF SAUDI ARABIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 758 KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 759 KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 760 KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 761 KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 762 KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 763 KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 764 KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 765 KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
  - 9.6.2.2 United Arab Emirates
    - 9.6.2.2.1 High production of biopharmaceuticals to support market growth
- TABLE 766 UNITED ARAB EMIRATES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 767 UNITED ARAB EMIRATES: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 768 UNITED ARAB EMIRATES: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 769 UNITED ARAB EMIRATES: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 770 UNITED ARAB EMIRATES: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 771 UNITED ARAB EMIRATES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 772 UNITED ARAB EMIRATES: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 773 UNITED ARAB EMIRATES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 774 UNITED ARAB EMIRATES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 775 UNITED ARAB EMIRATES: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 776 UNITED ARAB EMIRATES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 777 UNITED ARAB EMIRATES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 778 UNITED ARAB EMIRATES: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 779 UNITED ARAB EMIRATES: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
  - 9.6.2.3 Other GCC Countries
- TABLE 780 OTHER GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 781 OTHER GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 782 OTHER GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 783 OTHER GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 784 OTHER GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 785 OTHER GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 786 OTHER GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 787 OTHER GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 788 OTHER GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 789 OTHER GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 790 OTHER GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 791 OTHER GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 792 OTHER GCC COUNTRIES: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 793 OTHER GCC COUNTRIES: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- 9.6.3 REST OF MIDDLE EAST
- TABLE 794 REST OF MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 795 REST OF MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 796 REST OF MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 797 REST OF MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 798 REST OF MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 799 REST OF MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 800 REST OF MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 801 REST OF MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 802 REST OF MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 803 REST OF MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 804 REST OF MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 805 REST OF MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 806 REST OF MIDDLE EAST: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 807 REST OF MIDDLE EAST: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
9.7 AFRICA
- 9.7.1 INCREASING FOCUS ON CANCER DIAGNOSTICS TO SUPPORT MARKET GROWTH
- 9.7.2 AFRICA: RECESSION IMPACT
- TABLE 808 AFRICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 809 AFRICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 810 AFRICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 811 AFRICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 812 AFRICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 813 AFRICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 814 AFRICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 815 AFRICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 816 AFRICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 817 AFRICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 818 AFRICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 819 AFRICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 820 AFRICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 821 AFRICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION)

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- TABLE 822 DPCR AND QPCR MARKET: STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES
10.3 REVENUE ANALYSIS
- FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023 (USD MILLION)
10.4 MARKET SHARE ANALYSIS
- FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
- TABLE 823 DPCR AND QPCR MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 10.5.1 STARS
- 10.5.2 EMERGING LEADERS
- 10.5.3 PERVASIVE PLAYERS
- 10.5.4 PARTICIPANTS
- FIGURE 36 DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 10.5.5.1 Overall footprint
- FIGURE 37 DPCR AND QPCR MARKET: OVERALL FOOTPRINT
  - 10.5.5.2 Offering footprint
- TABLE 824 DPCR AND QPCR MARKET: OFFERING FOOTPRINT
  - 10.5.5.3 Application footprint
- TABLE 825 DPCR AND QPCR MARKET: APPLICATION FOOTPRINT
  - 10.5.5.4 End-user footprint
- TABLE 826 DPCR AND QPCR MARKET: END-USER FOOTPRINT
  - 10.5.5.5 Region footprint
- TABLE 827 DPCR AND QPCR MARKET: REGION FOOTPRINT
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 10.6.1 PROGRESSIVE COMPANIES
- 10.6.2 RESPONSIVE COMPANIES
- 10.6.3 DYNAMIC COMPANIES
- 10.6.4 STARTING BLOCKS
- FIGURE 38 DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
- 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- TABLE 828 DPCR AND QPCR MARKET: KEY STARTUPS/SMES
- TABLE 829 DPCR AND QPCR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7 COMPANY VALUATION & FINANCIAL METRICS
- FIGURE 39 EV/EBITDA OF KEY DPCR AND QPCR VENDORS
- FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY DPCR AND QPCR VENDORS
10.8 BRAND/PRODUCT COMPARISON ANALYSIS
- FIGURE 41 BRAND/PRODUCT COMPARISON ANALYSIS, BY DPCR AND QPCR OFFERINGS
10.9 COMPETITIVE SCENARIO
- 10.9.1 PRODUCT LAUNCHES & APPROVALS
- TABLE 830 DPCR AND QPCR MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
- 10.9.2 DEALS
- TABLE 831 DPCR AND QPCR MARKET: DEALS, JANUARY 2021-MAY 2024
- 10.9.3 EXPANSIONS
- TABLE 832 DPCR AND QPCR MARKET: EXPANSIONS, JANUARY 2021-MAY 2024

11 COMPANY PROFILES

11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

11.1.1 DANAHER CORPORATION
TABLE 833 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 834 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 835 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 836 DANAHER CORPORATION: DEALS, JANUARY 2021-MAY 2024
11.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 837 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
TABLE 838 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 839 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 840 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021-MAY 2024
11.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 841 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
TABLE 842 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 843 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 844 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MAY 2024
11.1.4 MERCK KGAA
TABLE 845 MERCK KGAA: COMPANY OVERVIEW
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023)
TABLE 846 MERCK KGAA: PRODUCTS OFFERED
11.1.5 QIAGEN N.V.
TABLE 847 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 46 QIAGEN N.V.: COMPANY SNAPSHOT (2023)
TABLE 848 QIAGEN N.V.: PRODUCTS OFFERED
TABLE 849 QIAGEN N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 850 QIAGEN N.V.: DEALS, JANUARY 2021-MAY 2024
11.1.6 BIO-RAD LABORATORIES, INC.
TABLE 851 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 852 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 853 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 854 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-MAY 2024
11.1.7 AGILENT TECHNOLOGIES, INC.
TABLE 855 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 48 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 856 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 857 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 858 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-MAY 2024
11.1.8 TAKARA BIO INC.
TABLE 859 TAKARA BIO INC.: COMPANY OVERVIEW
FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
TABLE 860 TAKARA BIO INC.: PRODUCTS OFFERED
TABLE 861 TAKARA BIO INC.: DEALS, JANUARY 2021-MAY 2024
11.1.9 BECTON, DICKINSON, AND COMPANY
TABLE 862 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
TABLE 863 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 864 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 865 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-MAY 2024
11.1.10 ABBOTT LABORATORIES
TABLE 866 ABBOTT LABORATORIES: COMPANY OVERVIEW
FIGURE 51 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
- 11.1.10.2 Products offered
TABLE 867 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 868 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
11.1.11 PROMEGA CORPORATION
TABLE 869 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 870 PROMEGA CORPORATION: PRODUCTS OFFERED
TABLE 871 PROMEGA CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
11.1.12 MERIDIAN BIOSCIENCE
TABLE 872 MERIDIAN BIOSCIENCE: COMPANY OVERVIEW
TABLE 873 MERIDIAN BIOSCIENCE: PRODUCTS OFFERED
TABLE 874 MERIDIAN BIOSCIENCE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 875 MERIDIAN BIOSCIENCE: DEALS, JANUARY 2021-MAY 2024
11.1.13 ENDRESS+HAUSER GROUP SERVICES AG
TABLE 876 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
FIGURE 52 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY SNAPSHOT (2023)
TABLE 877 ENDRESS+HAUSER GROUP SERVICES AG: PRODUCTS OFFERED
TABLE 878 ENDRESS+HAUSER GROUP SERVICES AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 879 ENDRESS+HAUSER GROUP SERVICES AG: DEALS, JANUARY 2021-MAY 2024
11.1.14 BIOMERIEUX
TABLE 880 BIOMERIEUX: COMPANY OVERVIEW
FIGURE 53 BIOMERIEUX: COMPANY SNAPSHOT (2023)
TABLE 881 BIOMERIEUX: PRODUCTS OFFERED
TABLE 882 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
11.1.15 EPPENDORF AG
TABLE 883 EPPENDORF AG: COMPANY OVERVIEW
FIGURE 54 EPPENDORF AG: COMPANY SNAPSHOT (2023)
TABLE 884 EPPENDORF AG: PRODUCTS OFFERED
11.1.16 QUIDELORTHO CORPORATION
TABLE 885 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
FIGURE 55 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 886 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
TABLE 887 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
TABLE 888 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-MAY 2024
11.1.17 ENZO BIOCHEM INC.
TABLE 889 ENZO BIOCHEM INC.: COMPANY OVERVIEW
FIGURE 56 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)
TABLE 890 ENZO BIOCHEM INC.: PRODUCTS OFFERED
TABLE 891 ENZO BIOCHEM INC.: DEALS, JANUARY 2021-MAY 2024
11.1.18 LEPU MEDICAL TECHNOLOGY CO., LTD.
TABLE 892 LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
FIGURE 57 LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2023)
TABLE 893 LEPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
11.1.19 SYSMEX CORPORATION
TABLE 894 SYSMEX CORPORATION: COMPANY OVERVIEW
FIGURE 58 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 895 SYSMEX CORPORATION: PRODUCTS OFFERED

11.2 STARTUP/SME PLAYERS
- 11.2.1 BIOCARTIS
- TABLE 896 BIOCARTIS: COMPANY OVERVIEW
- 11.2.2 STILLA
- TABLE 897 STILLA: COMPANY OVERVIEW
- 11.2.3 ANTYLIA SCIENTIFIC
- TABLE 898 ANTYLIA SCIENTIFIC: COMPANY OVERVIEW
- 11.2.4 BIONEER CORPORATION
- TABLE 899 BIONEER CORPORATION: COMPANY OVERVIEW
- 11.2.5 STANDARD BIOTOOLS
- TABLE 900 STANDARD BIOTOOLS: COMPANY OVERVIEW
- 11.2.6 SEEGENE INC.
- TABLE 901 SEEGENE INC.: COMPANY OVERVIEW
- 11.2.7 GENSCRIPT
- TABLE 902 GENSCRIPT: COMPANY OVERVIEW
- 11.2.8 LGC BIOSEARCH TECHNOLOGIES
- TABLE 903 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
- 11.2.9 QUANTABIO
- TABLE 904 QUANTABIO: COMPANY OVERVIEW
- 11.2.10 RANDOX LABORATORIES LTD.
- TABLE 905 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
- 11.2.11 NEW ENGLAND BIOLABS
- TABLE 906 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
- 11.2.12 PCR BIOSYSTEMS
- TABLE 907 PCR BIOSYSTEMS: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS